We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Krystal Biotech

News List

Australia grants Patent to Krystal Biotech biospectrumasia
October 08, 2019
This patent covers pharmaceutical compositions comprising KB103, as well as to medical uses thereof, e.g., in the treatment of wounds, disorders, or diseases of the skin, particularly those found in epidermolysis bullosa patients.
Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial (“GEM-2 study”) of KB103 and Receives Regenerative Medicine Advanced Therapy (“RMAT”) Designation from FDA for KB103 drugs
June 28, 2019
Krystal Biotech, Inc. (Nasdaq: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from rare dermatological diseases ...
Krystal Biotech Completes Construction of New GMP Facility americanpharmaceuticalreview
January 16, 2019
Krystal Biotech announced construction of Ancoris, a new state-of-the-art Good Manufacturing Practice (GMP) facility, is complete...